Cigna Group (CI)
(Real Time Quote from BATS)
$355.79 USD
-1.47 (-0.41%)
Updated Sep 20, 2024 11:32 AM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Income Statements
Fiscal Year end for Cigna Group falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 195,265 | 180,516 | 174,078 | 160,401 | 153,566 |
Cost Of Goods | 36,287 | 32,206 | 33,562 | 32,710 | 30,819 |
Gross Profit | 158,978 | 148,310 | 140,516 | 127,691 | 122,747 |
Selling & Adminstrative & Depr. & Amort Expenses | 150,442 | 139,896 | 132,581 | 119,538 | 114,670 |
Income After Depreciation & Amortization | 8,536 | 8,414 | 7,935 | 8,153 | 8,077 |
Non-Operating Income | -1,577 | 1,167 | 55 | 4,153 | 175 |
Interest Expense | 1,446 | 1,228 | 1,208 | 1,438 | 1,682 |
Pretax Income | 5,513 | 8,353 | 6,782 | 10,868 | 6,570 |
Income Taxes | 141 | 1,607 | 1,367 | 2,379 | 1,450 |
Minority Interest | 208 | 78 | 50 | 31 | 16 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 5,372 | 6,746 | 5,415 | 8,489 | 5,120 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5,164 | 6,668 | 5,365 | 8,458 | 5,104 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11,571 | 11,351 | 10,858 | 10,955 | 11,728 |
Depreciation & Amortization (Cash Flow) | 3,035 | 2,937 | 2,923 | 2,802 | 3,651 |
Income After Depreciation & Amortization | 8,536 | 8,414 | 7,935 | 8,153 | 8,077 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 296.95 | 313.07 | 340.97 | 368.38 | 379.76 |
Diluted EPS Before Non-Recurring Items | 25.09 | 23.27 | 20.47 | 18.45 | 17.05 |
Diluted Net EPS (GAAP) | 17.39 | 21.30 | 15.73 | 22.96 | 13.44 |
Fiscal Year end for Cigna Group falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 60,523.00 | 57,255.00 | 51,114.00 | 49,048.00 | 48,586.00 |
Cost Of Goods | 9,515.00 | 9,440.00 | 9,280.00 | 8,927.00 | 9,034.00 |
Gross Profit | 51,008.00 | 47,815.00 | 41,834.00 | 40,121.00 | 39,552.00 |
SG&A, R&D, and Dept/Amort Expenses | 48,596.00 | 45,559.00 | 39,774.00 | 37,881.00 | 37,331.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 2,412.00 | 2,256.00 | 2,060.00 | 2,240.00 | 2,221.00 |
Non-Operating Income | -48.00 | -1,855.00 | -1,512.00 | -35.00 | 26.00 |
Interest Expense | 375.00 | 322.00 | 360.00 | 365.00 | 363.00 |
Pretax Income | 1,989.00 | 79.00 | 188.00 | 1,840.00 | 1,884.00 |
Income Taxes | 360.00 | 291.00 | -919.00 | 391.00 | 374.00 |
Minority Interest | 81.00 | 65.00 | 78.00 | 41.00 | 50.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 1,629.00 | -212.00 | 1,107.00 | 1,449.00 | 1,510.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1,548.00 | -277.00 | 1,029.00 | 1,408.00 | 1,460.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 284.04 | 289.72 | 294.84 | 297.05 | 296.75 |
Diluted EPS Before Non-Recurring Items | 6.72 | 6.47 | 6.79 | 6.77 | 6.13 |
Diluted Net EPS (GAAP) | 5.45 | -0.97 | 3.49 | 4.74 | 4.92 |